Alligator Bioscience Logo

Alligator Bioscience

ATORX | ST

Overview

Corporate Details

ISIN(s):
SE0000767188 (+8 more)
LEI:
549300E15VI0MB7LXV19
Country:
Sweden
Address:
C/O Medicon Village, 223 81 Lund
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Alligator Bioscience is a clinical-stage biotechnology company focused on developing tumor-directed immuno-oncology antibody drugs. The company specializes in creating antibody-based pharmaceuticals for cancer treatment, with a primary focus on activating the CD40 receptor pathway to stimulate a patient's immune system against tumors. Its lead candidate, mitazalimab, is a CD40 agonist in late-stage clinical development for pancreatic cancer. Alligator Bioscience's business model is centered on advancing its pipeline of novel drug candidates through discovery, preclinical, and clinical development stages to commercialization.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Alligator Bioscience. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-08 22:10
Capital/Financing Update
Alligator Bioscience has renegotiated the outstanding loan from Fenja Capital a…
English 71.6 KB
2025-09-08 22:10
Capital/Financing Update
Alligator Bioscience har omförhandlat det utestående lånet från Fenja Capital o…
Swedish 71.7 KB
2025-08-27 21:00
Share Issue/Capital Change
Exercise price determined for the exercise of warrants series TO 13 in Alligato…
English 72.6 KB
2025-08-27 21:00
Share Issue/Capital Change
Teckningskurs fastställd för nyttjandet av teckningsoptioner serie TO 13 i Alli…
Swedish 72.8 KB
2025-07-21 12:18
Major Shareholding Notification
Swedish 10.9 KB
2025-07-17 11:38
Major Shareholding Notification
Swedish 10.9 KB
2025-07-10 10:49
Major Shareholding Notification
Swedish 10.9 KB
2025-07-10 08:00
Interim Report
Swedish 1.2 MB
2025-07-10 08:00
Interim Report
English 1.2 MB
2025-06-30 15:00
Declaration of Voting Results & Voting Rights Announcements
Ändring av antalet aktier och röster i Alligator Bioscience AB
Swedish 54.8 KB
2025-06-30 15:00
Declaration of Voting Results & Voting Rights Announcements
Change in number of shares and votes in Alligator Bioscience AB
English 54.1 KB
2025-06-26 10:21
Major Shareholding Notification
Swedish 9.9 KB
2025-06-25 10:35
Major Shareholding Notification
Swedish 11.1 KB
2025-06-23 14:35
Major Shareholding Notification
Swedish 11.1 KB
2025-06-19 10:42
Major Shareholding Notification
Swedish 11.1 KB

Automate Your Workflow. Get a real-time feed of all Alligator Bioscience filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Alligator Bioscience via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-02-28 Peter Ostler Other Sell 1,658,134 179,045.31 SEK
2024-04-11 Staffan Encrantz Other Sell 44,108,581 47,196,181.67 SEK
2022-10-27 Sören Bregenholt Frederiksen Other Buy 52,000 72,748.00 SEK
2022-10-25 Marie Svensson Other Buy 12,000 16,632.00 SEK
2022-08-19 Sören Bregenholt Frederiksen Other Buy 13,906 25,726.10 SEK
2022-08-18 Sören Bregenholt Frederiksen Other Buy 31,094 56,911.35 SEK
2022-05-31 Peter Ostler Other Buy 100,000 151,500.00 SEK
2022-05-04 Sören Bregenholt Frederiksen Other Buy 30,000 50,895.00 SEK
2022-05-02 Sören Bregenholt Frederiksen Other Buy 30,000 50,811.00 SEK
2022-04-30 Sören Bregenholt Frederiksen Other Buy 30,000 51,171.00 SEK

Peer Companies

Company Country Ticker View
VERICI DX PLC Logo
AI-powered diagnostic tests for the kidney transplant market, predicting organ rejection and injury.
United Kingdom VRCI
Vicore Pharma Holding Logo
Develops AT2 receptor drugs and a digital therapeutic for pulmonary fibrosis.
Sweden VICO
Vivoryon Therapeutics N.V. Logo
Develops small molecule therapies for severe age-related, inflammatory, and neurodegenerative diseases.
Germany VVY
R&D in renewable energy & manufacturing specialized tools for automotive & engineering.
Slovakia N/A
Xintela AB Logo
Develops stem cell therapies and targeted antibody treatments for cancer and osteoarthritis.
Sweden XINT
Xlife Sciences AG Logo
A life sciences incubator commercializing early-stage academic research for healthcare markets.
Switzerland XLS
XTL Biopharmaceuticals Ltd. Logo
Acquires and develops late-stage therapeutics for autoimmune diseases.
Israel XTLB
Yoshi Innovation Spolka Akcyjna Logo
A tech fund incubating MedTech, biotech, and defense ventures with investment and IP protection.
Poland YOS
Zealand Pharma Logo
Develops innovative peptide medicines for metabolic and rare diseases.
Denmark ZEAL
Ziccum AB Logo
Licenses drying tech for thermostable vaccines & biologics, eliminating the cold chain.
Sweden ZICC